Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
The efficacy of chemotherapeutic drug in cancer treatment is often hampered by drug resistance of tumor cells, which is usually caused by abnormal gene expression. RNA interference mediated by siRNA and miRNA can selectively knock down the carcinogenic genes by targeting specific mRNAs. Therefore, c...
Saved in:
Main Authors: | Lin Kang (Author), Zhonggao Gao (Author), Wei Huang (Author), Mingji Jin (Author), Qiming Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers
by: Patrícia V. Teixeira, et al.
Published: (2023) -
Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins
by: Ying Han, et al.
Published: (2019) -
The influence of the gut microbiota on the bioavailability of oral drugs
by: Xintong Zhang, et al.
Published: (2021) -
Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies
by: Yubo Wang, et al.
Published: (2024) -
Editor Profile: Guest Editors of the Special Issue "Functional Materials, Nanocarriers, and Formulations for Targeted Therapy"
by: Zhonggao Gao
Published: (2016)